Moore Capital Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-250,000
| Closed | -$643K | – | 528 |
|
|
2024
Q2 | $643K | Hold |
250,000
| – | – | 0.01% | 294 |
|
|
2024
Q1 | $1.23M | Buy |
250,000
+100,000
| +67% | +$492K | 0.02% | 244 |
|
|
2023
Q4 | $1.32M | Sell |
150,000
-10,000
| -6% | -$87.9K | 0.02% | 226 |
|
|
2023
Q3 | $1.84M | Buy |
160,000
+105,000
| +191% | +$1.2M | 0.03% | 207 |
|
|
2023
Q2 | $1.39M | Buy |
+55,000
| New | +$1.39M | 0.02% | 251 |
|
|
2014
Q3 | – | Sell |
-100,000
| Closed | -$3.4M | – | 477 |
|
|
2014
Q2 | $3.4M | Buy |
+100,000
| New | +$3.4M | 0.08% | 171 |
|